Grantham, Mayo, Van Otterloo & Co (GMO)
GILD icon

Grantham, Mayo, Van Otterloo & Co (GMO)’s Gilead Sciences GILD Stock Holding History

Grantham, Mayo, Van Otterloo & Co (GMO)’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$4.99M Sell
35,836
-76,362
-68% -$10.7M 0.01% 325
2025
Q4 		$13.8M Buy
112,198
+20,225
+22% +$2.46M 0.04% 214
2025
Q3 		$10.2M Buy
91,973
+68,006
+284% +$7.73M 0.03% 237
2025
Q2 		$2.66M Buy
23,967
+13,597
+131% +$1.45M 0.01% 351
2025
Q1 		$1.16M Sell
10,370
-2,698
-21% -$278K ﹤0.01% 439
2024
Q4 		$1.21M Sell
13,068
-47,570
-78% -$4.28M ﹤0.01% 419
2024
Q3 		$5.08M Sell
60,638
-172,623
-74% -$13.2M 0.02% 324
2024
Q2 		$16M Buy
+233,261
New +$15.6M 0.05% 228
2024
Q1 		– Sell
-286,270
Closed -$23.2M – 525
2023
Q4 		$23.2M Buy
286,270
+37,031
+15% +$2.88M 0.1% 151
2023
Q3 		$18.7M Sell
249,239
-20,565
-8% -$1.58M 0.09% 190
2023
Q2 		$20.8M Sell
269,804
-19,880
-7% -$1.59M 0.1% 178
2023
Q1 		$24M Buy
289,684
+44,704
+18% +$3.7M 0.12% 159
2022
Q4 		$21M Sell
244,980
-299,016
-55% -$23.7M 0.11% 175
2022
Q3 		$33.6M Sell
543,996
-35,900
-6% -$2.26M 0.19% 104
2022
Q2 		$35.8M Buy
579,896
+91,200
+19% +$5.65M 0.19% 96
2022
Q1 		$29.1M Buy
488,696
+74,696
+18% +$4.77M 0.14% 129
2021
Q4 		$30.1M Sell
414,000
-1,900
-0.5% -$131K 0.14% 118
2021
Q3 		$29.1M Buy
415,900
+43,400
+12% +$3.05M 0.14% 121
2021
Q2 		$25.6M Buy
372,500
+88,600
+31% +$5.92M 0.13% 136
2021
Q1 		$18.3M Buy
283,900
+108,870
+62% +$7.02M 0.1% 163
2020
Q4 		$10.2M Buy
175,030
+93,700
+115% +$5.65M 0.06% 194
2020
Q3 		$5.14M Buy
81,330
+100
+0.1% +$6.93K 0.04% 234
2020
Q2 		$6.25M Buy
81,230
+31,461
+63% +$2.41M 0.05% 217
2020
Q1 		$3.72M Sell
49,769
-122,655
-71% -$8.48M 0.03% 284
2019
Q4 		$11.2M Sell
172,424
-42,076
-20% -$2.74M 0.07% 179
2019
Q3 		$13.6M Sell
214,500
-38,300
-15% -$2.5M 0.09% 149
2019
Q2 		$17.1M Buy
252,800
+6,900
+3% +$454K 0.12% 129
2019
Q1 		$16M Buy
+245,900
New +$16.3M 0.12% 134
2018
Q3 		– Sell
-9,600
Closed -$680K – 554
2018
Q2 		$680K Buy
9,600
+300
+3% +$21.2K ﹤0.01% 430
2018
Q1 		$701K Hold
9,300
– – ﹤0.01% 417
2017
Q4 		$666K Buy
+9,300
New +$706K ﹤0.01% 418
2017
Q3 		– Sell
-6,800
Closed -$481K – 588
2017
Q2 		$481K Sell
6,800
-30,600
-82% -$2.04M ﹤0.01% 418
2017
Q1 		$2.54M Sell
37,400
-837,284
-96% -$58.9M 0.01% 302
2016
Q4 		$62.6M Sell
874,684
-291,032
-25% -$21.6M 0.34% 82
2016
Q3 		$92.2M Buy
1,165,716
+742,616
+176% +$60.3M 0.44% 55
2016
Q2 		$35.3M Buy
423,100
+325,500
+334% +$28.9M 0.14% 130
2016
Q1 		$8.97M Buy
97,600
+94,000
+2,611% +$8.48M 0.03% 243
2015
Q4 		$364K Hold
3,600
– – ﹤0.01% 467
2015
Q3 		$353K Hold
3,600
– – ﹤0.01% 500
2015
Q2 		$421K Sell
3,600
-1,000
-22% -$109K ﹤0.01% 404
2015
Q1 		$451K Hold
4,600
– – ﹤0.01% 396
2014
Q4 		$434K Sell
4,600
-2,100
-31% -$217K ﹤0.01% 401
2014
Q3 		$713K Sell
6,700
-3,900
-37% -$382K ﹤0.01% 396
2014
Q2 		$879K Sell
10,600
-506,346
-98% -$39.4M ﹤0.01% 415
2014
Q1 		$36.6M Sell
516,946
-2,869,791
-85% -$225M 0.1% 108
2013
Q4 		$255M Buy
3,386,737
+464,338
+16% +$32.3M 0.62% 32
2013
Q3 		$184M Buy
2,922,399
+391,794
+15% +$23.4M 0.48% 38
2013
Q2 		$130M Buy
+2,530,605
New +$132M 0.34% 49

Other funds holding GILD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Grantham, Mayo, Van Otterloo & Co (GMO)'s GILD Position: Q1 2026 in Review

Grantham, Mayo, Van Otterloo & Co (GMO) reduced its Gilead Sciences (GILD) stake by 68% in Q1 2026, selling an estimated $10.7M and leaving 35,836 shares worth $4.99M. The position accounts for 0.01% of the portfolio, ranked #325.

Grantham, Mayo, Van Otterloo & Co (GMO) first reported a position in GILD in Q2 2013 and has held it in 48 quarters since. The position peaked at $255M in Q4 2013. 2,309 funds tracked by Wall St. Rank hold GILD as of Q1 2026.

  • Grantham, Mayo, Van Otterloo & Co (GMO) held 35,836 shares of Gilead Sciences worth $4.99M as of Q1 2026.
  • Grantham, Mayo, Van Otterloo & Co (GMO) sold 76,362 Gilead Sciences shares in Q1 2026, an estimated $10.7M.
  • Gilead Sciences made up 0.01% of Grantham, Mayo, Van Otterloo & Co (GMO)'s portfolio in Q1 2026, its #325 holding.
  • Grantham, Mayo, Van Otterloo & Co (GMO) first reported a position in Gilead Sciences in Q2 2013 and has held it in 48 quarters since.
  • Grantham, Mayo, Van Otterloo & Co (GMO)'s Gilead Sciences position peaked at $255M in Q4 2013.
  • 2,309 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2026.

Based on Grantham, Mayo, Van Otterloo & Co (GMO)'s 13F filing for Q1 2026, filed 14 May 2026.